Here are relevant reports on : personalized-health-market
-
Antimicrobial Resistance Surveillance Market by Solution (Kits, System, Surveillance Software, Service), Application (Clinical Diagnostics, Public Health Surveillance), End User (Hospitals, Clinics, Academic, Research Institutes) & Region - Global Forecast to 2028
The global antimicrobial resistance (AMR) surveillance market, valued at US$5.4 billion in 2021, stood at US$5.9 billion in 2023 and is projected to advance at a resilient CAGR of 5.6% from 2023 to 2028, culminating in a forecasted valuation of US$7.7 billion by the end of the period.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Dairy Herd Management Market by Hardware (Milk Management, Feeding Management Systems, Herd Health Management, Sorting Systems), Software, Services (Installation Services, Consulting Services), Application (Breeding, Feeding) - Global Forecast to 2032
The global dairy herd management market, valued at US$4.16 billion in 2024, stood at US$4.99 billion in 2025 and is projected to advance at a resilient CAGR of 8.6% from 2025 to 2032, culminating in a forecasted valuation of US$8.88 billion by the end of the period. Key factors fueling market growth include increasing demand for high-quality dairy products, growing herd size, and rising adoption of automated milking systems.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Behavioral/Mental Health Software Market by Component (Software), Application (Clinical (EHR, CDS, Medication), Admin, Patient Engagement (Telepsychiatry), RCM), Indication (Mood Disorders, Anxiety, Substance Use), End User - Global Forecast to 2031
The global behavioral/mental health software market is projected to reach USD 8.43 billion by 2031, growing at a CAGR of 12.7% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
North America Blood Glucose Monitoring Devices Market by Product Type (Self-monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site, End User (Self/Homecare) - Forecast to 2030
The North America Blood Glucose Monitoring Devices market, valued at USD 6.02 billion in 2024, stood at USD 6.52 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of USD 9.93 billion by the end of the period. The North America blood glucose monitoring devices market is experiencing steady growth, driven by several key factors. Rising diabetes prevalence, fueled by aging populations, urbanization, and lifestyle changes, is increasing demand for effective self-monitoring solutions.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Healthcare Interoperability Solutions Market by Type (Software (EHR, Lab System, Imaging, Health Information Exchange, Enterprises), and Services), Interoperability Level (Foundational, Structural, Semantic), End User, and Region - Global Forecast to 2027
The global Healthcare interoperability solutions market, valued at US$3.0 billion in 2021, stood at US$3.4 billion in 2022 and is projected to advance at a resilient CAGR of 12.9% from 2022 to 2027, culminating in a forecasted valuation of US$6.2 billion by the end of the period. Growth in this market is driven by the government funding to increase adption of healthcare interoperability solutions, and the emergence of new technologies.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Precision Nutrition Market by Technology (Metabolomics, Genomics, Transcriptomics, Proteomics), Application (Disease Management, General Health & Wellness, Weight Management), Service Type, End-Use, Supplement, and Region - Global Forecast to 2029
The market for precision nutrition is projected to reach USD 12.89 billion by 2029, at a CAGR of 16.2% during the forecast period. The report profiles key players such as Viome Life Sciences, Inc. (US), Prenetics Global Limited (China), ZOE Limited (UK), myDNA Life Australia Pty Ltd. (Australia) , 23andMe, Inc. (US), DayTwo Inc (US), Nutrigenomix (Canada), Genesis Healthcare Co. (Japan), AMILI (Singapore), and SelfDecode (US).
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Functional Food Ingredients Market by Type (Probiotics, Protein & Amino Acids, Phytochemicals & Plant Extracts, Prebiotics, Omega-3 Fatty Acids, Carotenoids, Vitamins), Application, Source, Form, Health Benefits and Region - Global Forecast to 2029
The global functional food ingredients market size is projected to reach USD 119.2 billion, displaying a promising Compound Annual Growth Rate (CAGR) of 6.8% during the forecasting period. The key players in this market include Cargill, Incorporated (US), BASF SE (Germany), ADM (US), International Flavors & Fragrances Inc. (US), Arla Foods amba (Denmark), Kerry Group plc (Ireland), Ajinomoto Co., Inc. (Japan), DSM (Netherlands), Ingredion (US), Tate & Lyle (UK), and TEIJIN LIMITED (Japan).
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Digital Biomarkers Market by Type (Physiological, Vocal, Idiosyncratic), Therapy [Cardio, Onco (Lung, Breast Cancer), Mental Health, Neuro], Application [Clinical Research (Phase IV)], End User (Pharma & Biotech Companies, CROs) – Global Forecast to 2031
The global digital biomarkers market is projected to reach USD 17.73 billion by 2031, growing at a CAGR of 19.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Wastewater Surveillance Market by Product (Instruments & Equipment (Samplers, Ultracentrifuge, qPCR, Portable), Assays & Kits, Consumables), Application (Pathogen Detection, AMR Tracking), End User (Public Health, Govt, Hospitals) - Global Forecast to 2030
The global wastewater surveillance market, valued at US$0.82 billion in 2024, stood at US$0.88 billion in 2025 and is projected to advance at a resilient CAGR of 6.7% from 2024 to 2030, culminating in a forecasted valuation of US$1.22 billion by the end of the period. Wastewater surveillance is increasingly seen as a reliable early warning tool for public health threats, including asymptomatic infections like polio, mpox, and antimicrobial resistance (AMR)
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Obama’s Healthcare Reform Bill and its Impact on the U.S. Healthcare Markets – (Pharmaceuticals, Medical devices and Health insurance)
The US healthcare system ranks 37 among health care systems of about 200 worldwide countries ranked by World Health Organization. US health care system is considered as one of the most expensive healthcare system in the world, spending about 16% of its GDP on healthcare. However the rising healthcare costs and increasing health premiums rates along with high number of uninsured people (about 47 million i.e. 16% of the total population) are among the significant factors contributing to the need of health reform in the US. Health reform in the US is looked upon as an initiative towards provision of qualitative and affordable health coverage for all Americans, decrease in rising burden of healthcare costs and improvement in quality & efficiency of health care. Obama has signed health reform in to law, recently in March 2010, to improve the inefficiencies of the existing health care structure. The health reform bill outlays several provisions such as universal health coverage, cost containment, increase in insurance market competition, excise tax on medical device manufacturers and lower drug costs for Medicaid and Medicare are few to mention. Thus the provisions in the health reform directly and indirectly impact the US healthcare/pharmaceutical industry and its stakeholders.
- Published: August 2010
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
